Anjana Devi Tangutur
-
- Epigenetics and DNA Methylation 3
- Cancer therapeutics and mechanisms 3
- Histone Deacetylase Inhibitors Research 3
-
- Bioactive Compounds and Antitumor Agents 3
-
- Sirtuins and Resveratrol in Medicine 2
-
- Autophagy in Disease and Therapy 5
-
- Berberine and alkaloids research 3
-
- Synthesis and biological activity 3
Anjana Devi Tangutur
26 papers receiving 599 citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Drug Discovery 1
- Molecular Biology 381
- Toxicology 16
- Geriatrics and Gerontology 17
- Cancer Research 63
Countries citing papers authored by Anjana Devi Tangutur
This map shows the geographic impact of Anjana Devi Tangutur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anjana Devi Tangutur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anjana Devi Tangutur more than expected).
Fields of papers citing papers by Anjana Devi Tangutur
This network shows the impact of papers produced by Anjana Devi Tangutur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anjana Devi Tangutur. The network helps show where Anjana Devi Tangutur may publish in the future.
Co-authorship network
The 23 scholars most cited alongside Anjana Devi Tangutur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 39 | |
| 7 | 2021 | 2 | |
| 8 | Epigenetic modulation and understanding of HDAC inhibitors in cancer therapybreakdown → | 2021 | 226 |
| 9 | 2021 | 5 | |
| 10 | 2021 | 8 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 3 | |
| 13 | 2020 | 2 | |
| 14 | 2020 | 11 | |
| 15 | 2020 | 7 | |
| 16 | 2019 | 30 | |
| 17 | 2018 | 21 | |
| 18 | 2017 | 119 | |
| 19 | 2016 | 12 | |
| 20 | 2013 | 57 |
About Anjana Devi Tangutur
Anjana Devi Tangutur is a scholar working on Toxicology, Geriatrics and Gerontology and Physiology, having authored 26 papers that have together received 608 indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (5 papers), Bioactive Compounds and Antitumor Agents (3 papers), Berberine and alkaloids research (3 papers), Synthesis and biological activity (3 papers), Epigenetics and DNA Methylation (3 papers), Cancer therapeutics and mechanisms (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Sirtuins and Resveratrol in Medicine (2 papers). The work is most often cited by research in Drug Discovery (1 citation), Molecular Biology (381 citations) and Toxicology (16 citations). Anjana Devi Tangutur has collaborated with scholars based in India and Nigeria. Frequent co-authors include M. Janaki Ramaiah, M. Rajasekhar Reddy, Srinivas Kantevari, Dinesh Kumar, Nivedita Sahu, Debabrata Chowdhury, Priyanka Saxena, S. Banerjee, Tarak Nath Khatua and Bhima Bhukya. Their work appears in journals such as Gene, Life Sciences and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.